Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Killen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|January 1, 1984
Problems in the therapy of AIDS-associated malignanciesR E Wittes, J Y Killen
The Journal of Dermatologic Surgery and Oncology|May 1, 1980
The malignant lymphomas: current concepts of diagnosis and managementJ Y Killen, P S Schein
Current Problems in Cancer|April 1, 1986
Small cell bronchogenic carcinomaM Perloff, J Y Killen, R E Wittes
AIDS Research and Human Retroviruses|January 1, 1994
Recent advances in AIDS vaccine research and developmentM I Johnston, J S Noe, J Y Killen
The Journal of Infectious Diseases|November 1, 1985
Classification of HTLV-III/LAV-related diseasesH W Haverkos, M S Gotlieb, J Y Killen, et al.
American Journal of Ophthalmology|March 1, 1980
Optic neuritis and systemic lymphomaJ C Kattah, E T Suski, J Y Killen, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
The New England Journal of Medicine|November 3, 1983
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)J D Boice, M H Greene, J Y Killen, et al.
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
The New England Journal of Medicine|January 9, 1986
Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effectJ D Boice, M H Greene, J Y Killen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|January 1, 1984
Problems in the therapy of AIDS-associated malignanciesR E Wittes, J Y Killen
The Journal of Dermatologic Surgery and Oncology|May 1, 1980
The malignant lymphomas: current concepts of diagnosis and managementJ Y Killen, P S Schein
Current Problems in Cancer|April 1, 1986
Small cell bronchogenic carcinomaM Perloff, J Y Killen, R E Wittes
AIDS Research and Human Retroviruses|January 1, 1994
Recent advances in AIDS vaccine research and developmentM I Johnston, J S Noe, J Y Killen
The Journal of Infectious Diseases|November 1, 1985
Classification of HTLV-III/LAV-related diseasesH W Haverkos, M S Gotlieb, J Y Killen, et al.
American Journal of Ophthalmology|March 1, 1980
Optic neuritis and systemic lymphomaJ C Kattah, E T Suski, J Y Killen, et al.
Cancer Treatment Reports|November 1, 1981
Phase II study of PCNU in colorectal carcinomaE P Mitchell, J Y Killen, F P Smith, et al.
The New England Journal of Medicine|November 3, 1983
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)J D Boice, M H Greene, J Y Killen, et al.
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
The New England Journal of Medicine|January 9, 1986
Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effectJ D Boice, M H Greene, J Y Killen, et al.
Pageof 1